CMG Pharmaceutical Co (XKRX:058820) COGS-to-Revenue : 0.54 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co COGS-to-Revenue?

CMG Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩12,417 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩22,814 Mil.

CMG Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CMG Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 45.57%.

CMG Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for CMG Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMG Pharmaceutical Co COGS-to-Revenue Chart

CMG Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.51

0.52

0.50

0.53

CMG Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.53	0.49	0.54	0.58	0.54

CMG Pharmaceutical Co COGS-to-Revenue Calculation

CMG Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	50203.948	/	93906.675
	=	0.53

CMG Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	12417.463	/	22813.683
	=	0.54

CMG Pharmaceutical Co (XKRX:058820) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CMG Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	12417.463 / 22813.683
	=	45.57 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

CMG Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CMG Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CMG Pharmaceutical Co (XKRX:058820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949

Website

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines